ClinicalTrials.govrestricted
Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT01386398. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8
Topics
Dataset details
- Repository
- ClinicalTrials.gov
- Published
- February 11, 2026
- License
- IPD-UNDECIDED
- DOI
- clinicaltrials.gov/NCT01386398
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.